Back to Search
Start Over
Long‐term response to crizotinib in a 17‐year‐old boy with treatment‐naïve ALK‐positive non‐small‐cell lung cancer.
- Source :
- Cancer Reports; Mar2022, Vol. 5 Issue 3, p1-4, 4p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 25738348
- Volume :
- 5
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Cancer Reports
- Publication Type :
- Academic Journal
- Accession number :
- 155950900
- Full Text :
- https://doi.org/10.1002/cnr2.1483